Literature DB >> 24835922

The availability of pre- and intraoperative evaluation of a solitary pulmonary nodule in breast cancer patients.

Tomonari Kinoshita1, Junji Yoshida, Genichiro Ishii, Tomoyuki Hishida, Masahiro Wada, Keiju Aokage, Kanji Nagai.   

Abstract

PURPOSE: It is clinically difficult to differentiate between primary lung cancer (PLC) and metastasis from breast cancer (MBC) in the diagnosis of a solitary pulmonary nodule (SPN) observed in a patient with past history of breast cancer. We evaluated several clinical, radiological and pathological variables in patients with SPN in an attempt to identify reliable markers to differentiate them.
METHODS: Retrospectively we reviewed the clinical, radiological and pathological characteristics of 64 patients with a history of breast cancer resection who subsequently underwent surgical resection of an indeterminate SPN in our institute.
RESULTS: The patients with MBC were significantly younger (p = 0.01). Among CT findings, presence of a solid opacity (p <0.01), well-defined tumor (p <0.01) and absence of an air bronchogram (p <0.01) were significantly associated with MBC. Among the intraoperative frozen section pathologic findings, the absence of lepidic or papillary patterns (p <0.01) and the presence of strong fibrosis in the tumor (p <0.01) were significantly correlated with MBC.
CONCLUSION: Although some cases are difficult to confirm the definitive diagnoses of SPN, combining CT and intraoperative pathological findings might enable us to distinguish SPN between MBC and PLC prior to postoperative examinations.

Entities:  

Mesh:

Year:  2014        PMID: 24835922      PMCID: PMC4989984          DOI: 10.5761/atcs.oa.14-00025

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  7 in total

1.  Adenocarcinoma in females detected in serous effusions. Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20.

Authors:  A Longatto Filho; H Bisi; V A Alves; C T Kanamura; M S Oyafuso; J Bortolan; V Lombardo
Journal:  Acta Cytol       Date:  1997 Jul-Aug       Impact factor: 2.319

2.  Air-space pattern in lung metastasis from adenocarcinoma of the GI tract.

Authors:  M Gaeta; S Volta; E Scribano; G Loria; A Vallone; I Pandolfo
Journal:  J Comput Assist Tomogr       Date:  1996 Mar-Apr       Impact factor: 1.826

3.  Primary and metastatic bronciolo-alveolar carcinoma.

Authors:  M B Rosenblatt; J R Lisa; F Collier
Journal:  Dis Chest       Date:  1967-08

4.  The role of surgery in the management of solitary pulmonary nodule in breast cancer patients.

Authors:  O Rena; E Papalia; E Ruffini; P L Filosso; A Oliaro; G Maggi; C Casadio
Journal:  Eur J Surg Oncol       Date:  2007-01-30       Impact factor: 4.424

5.  Mucus-secreting 'alveolar-cell' tumour of the lung: a histochemical comparison of tumours arising within and outside the lung.

Authors:  C S Foster
Journal:  Histopathology       Date:  1980-09       Impact factor: 5.087

6.  Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Authors:  Noriko Motoi; Janos Szoke; Gregory J Riely; Venkatraman E Seshan; Mark G Kris; Valerie W Rusch; William L Gerald; William D Travis
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

7.  The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas.

Authors:  Judit Moldvay; M Jackel; K Bogos; I Soltész; L Agócs; G Kovács; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

  7 in total
  1 in total

1.  18 Fluorodeoxyglucose-positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment.

Authors:  Lei Zhu; Haiman Bian; Lieming Yang; Jianjing Liu; Wei Chen; Xiaofeng Li; Jian Wang; Xiuyu Song; Dong Dai; Zhaoxiang Ye; Wengui Xu; Xiaozhou Yu
Journal:  Thorac Cancer       Date:  2019-03-21       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.